Warning: mysql_connect(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /home/ijcmasc1/public_html/ijcrar.com/IjcrarBackOffice/ConfigDB/DBCon.php on line 2

Deprecated: mysql_connect(): The mysql extension is deprecated and will be removed in the future: use mysqli or PDO instead in /home/ijcmasc1/public_html/ijcrar.com/IjcrarBackOffice/ConfigDB/DBCon.php on line 2
International Journal of Current Research and Academic Review-e-iSSN - 2347 - 3215

IJCRAR is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCRAR Articles.

INDEXED IN INDEX COPERNICUS - ICI Journals Master List 2016 - IJCRAR--ICV 2016: 81.15 For more details click here

Abstract                 Volume:5  Issue-1  Year-2017          Original Research Articles

Online ISSN : 2347 - 3215
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcret@gmail.com

Estimation of Serum Total Bilirubin Level and Hyponatremic Effect Associated with the Use of Levetiracetam Therapy in Epileptic Patients
Lincy Joseph1, Mathew George2 and Lintu Mariam Joshua2*
1Department of Pharmaceutical Chemistry, Pushpagiri College of Pharmacy, Thiruvalla-689107, Kerala, India
2Department of Pharmacology, Pushpagiri College of Pharmac, Thiruvalla-689107, Kerala, India
*Corresponding author

Epilepsy is a group of neurological diseases characterized by epileptic seizures. Levetiracetam is increasingly used as adjunctive anticonvulsant therapy. Levetiracetam is second generation anti epileptic drug. The present review is aimed on the estimation of serum total bilirubin level and hyponatremic effect associated with the use of levetiracetam therapy in epileptic patients. The clinical monitoring of the serum sodium levels is done to identify the development of hyponatremia associated with the use of levetiracetam. Asymptomatic elevation in serum total bilirubin is found in patients taking levetiracetam. The review provides clinical information about the incidence of hyponatremia and serum total bilirubin level associated with levetiracetam therapy.

Keywords: Epileptic patients, levetiracetam, serum total bilirubin level, hyponatremia, Clinical monitoring.
Download this article as Download

How to cite this article:

Lincy Joseph, Mathew George, Lintu Mariam Joshua. 2017. Estimation of Serum Total Bilirubin Level and Hyponatremic Effect Associated with the Use of Levetiracetam Therapy in Epileptic Patients.Int.J.Curr.Res.Aca.Rev. 5(1): 94-97
doi: http://dx.doi.org/10.20546/ijcrar.2017.501.011